- Report
- March 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- March 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- February 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- February 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- February 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- February 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- February 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- February 2026
- 250 Pages
Global
From €4223EUR$4,490USD£3,523GBP
- Report
- May 2026
- 180 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- January 2026
- 180 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- July 2026
- 135 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- August 2026
- 187 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- August 2026
- 120 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- August 2026
- 115 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- July 2026
- 180 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- July 2026
- 195 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- May 2026
- 350 Pages
Global
From €4655EUR$4,949USD£3,883GBP
- Report
- June 2026
- 383 Pages
Global
From €2351EUR$2,500USD£1,961GBP
- Report
- November 2026
- 477 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- February 2026
- 134 Pages
Global
From €4561EUR$4,850USD£3,805GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more